FDA 483 - Toaster Labs, Inc. - April 04, 2023

Toaster Labs, Inc. in Seattle, WA, a manufacturer of personal lubricants, was cited for significant deficiencies in its quality system during an FDA inspection. The firm failed to adequately establish procedures for medical device reporting, corrective and preventive actions, and supplier management, indicating a systemic breakdown in quality control.